<table sstyle="width:80%" align="center" border=1>
<tr>
<th>mv</th>
<th>dw</th>
<th>HMMCrowd</th>
</tr>
<tr>
<td width=33%>
[4, 5] paromomycin<br>[102, 112] paromomycin sulfate (3 x 1 g/day) or placebo<br></td>
<td width=33%>
[4, 5] paromomycin<br>[19, 21] placebo-<br>[100, 112] receive either paromomycin sulfate (3 x 1 g/day) or placebo<br>[187, 189] paromomycin,<br>[194, 196] placebo,<br>[266, 267] paromomycin<br></td>
<td width=33%>
[4, 5] paromomycin<br>[19, 21] placebo-<br>[100, 130] receive either paromomycin sulfate (3 x 1 g/day) or placebo in a double-blind fashion for at least 3 weeks, and if possible 4 weeks.<br>[131, 147] concentration, liver function tests, and other laboratory parameters were determined in weekly intervals.<br>[159, 162] paromomycin or placebo<br>[187, 189] paromomycin,<br>[194, 196] placebo,<br>[224, 227] (paromomycin,<br>[232, 234] placebo,<br>[244, 245] paromomycin<br>[266, 267] paromomycin<br></td>
</tr>
